GLP-2 (TIR) – Research Peptide

Product Overview

Tirzepatide is a synthetic dual-agonist peptide used in laboratory research to study metabolic signaling and peptide-mediated hormonal pathways. It activates both GLP-1 and GIP receptor pathways, allowing researchers to investigate dual-receptor dynamics and compare single- vs. multi-pathway interactions in controlled experimental models.

Scientific Research Focus

In laboratory studies, Tirzepatide is commonly explored for:

• GLP-1 receptor activation and signaling
• GIP receptor activation and pathway analysis
• Comparative studies of single vs. dual receptor activation
• Experimental modeling of energy regulation and nutrient-processing pathways
• Glucose-related signaling and insulin communication in controlled settings
• Long-acting peptide behavior and stability in lab models
• Analysis of coordinated hormonal responses in metabolic research

Researchers use Tirzepatide to examine how dual receptor activation influences metabolic pathways, cellular signaling, and peptide-mediated endocrine interactions in precise laboratory conditions.

Laboratory Relevance

Tirzepatide is frequently incorporated into studies involving:

• Dual-pathway receptor interaction mapping
• Controlled evaluation of metabolic and endocrine signaling
• Comparative peptide research with GLP-1–only analogues
• Analytical testing, stability profiling, and reproducibility verification
• Experimental modeling of multi-receptor coordination in cellular systems

Its dual-agonist properties make Tirzepatide a valuable tool for advanced research on metabolic signaling, peptide receptor dynamics, and endocrine pathway regulation.

Quality & Preparation

Each vial is produced under strict laboratory conditions to ensure stability, purity, and reproducibility. The lyophilized form supports precise handling and reliable results for research applications.

For laboratory research use only.
Not for human consumption, medical use, diagnostic use, or veterinary applications.